SmithKline Smoking Cessation Sales Reach $609 Mil. In 1999
This article was originally published in The Tan Sheet
Executive Summary
SmithKline Beecham's smoking cessation franchise grew 23% worldwide in 1999, posting sales of $609 mil., the company reported Feb. 16. Fourth quarter sales rose 10% to $184 mil.
You may also be interested in...
GlaxoSmithKline Merger Completion Delayed To Year-End
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.
GlaxoSmithKline Merger Completion Delayed To Year-End
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.
GlaxoSmithKline Merger Completion Delayed To Year-End
The planned merger of SmithKline Beecham and Glaxo Wellcome will be delayed, likely until the end of the year, due to continued Federal Trade Commission inquiries.